Tomi Environmental Solutions I Stock Price, News & Analysis

TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination and infection prevention company, announced its participation in the H.C. Wainwright 25th Annual Global Investment Conference. The presentation is scheduled for September 10, 2025, at 1:00 PM ET in the Stanford Room at the Lotte New York Palace Hotel in New York City.

CEO Dr. Halden Shane and CFO David Vanston will represent the company, which specializes in disinfection and decontamination through its proprietary Binary Ionization Technology (BIT) platform and SteraMist products. The technology, developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP) for superior disinfection across various sectors including healthcare, biosafety, pharmaceutical, commercial, and education facilities.

TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination technology provider, reported Q2 2025 financial results showing mixed performance. Revenue declined to $1.03M from $3.01M in Q2 2024, while maintaining a strong gross margin of 66%. Service revenue grew 33% year-over-year to $378,000.

The company reported a net loss of $1.24M ($0.06 per share) compared to net income of $30,000 in Q2 2024. Notable highlights include a sales order backlog of $1.4M and combined recognized revenue, deferred revenue, and backlog of $4.6M. TOMI is pursuing approximately $15M in opportunities, with $7M designated as high priority.

The company completed a $435,000 convertible note financing and maintains working capital of $2.8M. Management is focused on expanding recurring service contracts, growing solution sales, and strengthening its corporate team.

TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination and infection prevention company, has secured significant orders from a major eye health company. The customer placed orders for multiple Surface Units and disinfection carts for facilities in South Carolina and Florida, with expected total purchases of $385,000 for 2025.

The South Carolina facility has successfully completed validation testing, demonstrating SteraMist's effectiveness against Geobacillus stearothermophilus spores. The Florida facility is scheduled for qualification using the same methodology. This expansion validates TOMI's Binary Ionization Technology® (BIT™) platform, which uses ionized Hydrogen Peroxide (iHP™) technology for superior disinfection in regulated environments.

TOMI Environmental Solutions (NASDAQ: TOMZ), a global decontamination and infection prevention company, has scheduled its Q2 2025 earnings conference call for August 14, 2025, at 4:30 p.m. ET. The company will release its financial results for the quarter ended June 30, 2025, after market close on the same day.

TOMI specializes in disinfection solutions through its proprietary Binary Ionization Technology® (BIT™) platform, which was developed under a DARPA defense grant. The technology uses ionized Hydrogen Peroxide (iHP™) and serves various sectors including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings.

TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination and infection prevention company, has secured its fourth order for the SteraMist Integration System (SIS) platform from ARES Distribution. The order, placed for a biomedical research university in Coral Gables, Florida, is scheduled for delivery in late 2025.

The company's proprietary Binary Ionization Technology® (BIT™), developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP™) technology for superior disinfection. The technology serves various sectors including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings.

TOMI Environmental Solutions (NASDAQ:TOMZ), a global decontamination solutions provider, has announced the successful first installation of its SteraMist Integration System – Standalone (SIS-SA) in the life sciences sector, specifically for the pharmaceutical isolator market. The installation was completed at a leading pharmaceutical CDMO that had previously invested in SteraMist technology.

The company expects to generate over $500,000 in revenue from the new SIS-SA product in fiscal 2025. With the life science sterility testing market projected to reach $3.4 billion by 2031 at a CAGR of 12.4%, TOMI is positioning itself to capitalize on the growing demand for sterile drug manufacturing environments through its innovative Binary Ionization Technology® (BIT™) platform.

TOMI Environmental Solutions (NASDAQ: TOMZ) has demonstrated significant progress in addressing honeybee colony collapse through its SteraMist technology. A USDA study published on June 2, 2025, showed that SteraMist's ionized hydrogen peroxide effectively inactivates Deformed Wing Virus (DWV), a major cause of colony loss. This breakthrough comes as commercial beekeepers report up to 60% colony losses in early 2025, representing a $600 million economic impact. The solution targets DWV strains A and B, which are spread by miticide-resistant Varroa destructor mites. The development is crucial for protecting honeybees, which contribute $20-30 billion annually to the U.S. agricultural economy and $387 billion globally. TOMI's non-toxic approach offers beekeepers a practical tool to protect colonies and safeguard global food security.

TOMI Environmental Solutions (NASDAQ: TOMZ), a global disinfection and decontamination solutions provider, has been awarded the 'Disinfection and Decontamination Products Company of the Year 2025' by MedTech Outlook. The selection was made by a panel of C-level executives, industry thought leaders, and editorial board members, recognizing TOMI's SteraMist iHP technology. The company's Binary Ionization Technology (BIT) platform, developed under a DARPA defense grant, uses ionized Hydrogen Peroxide (iHP) technology for superior disinfection. SteraMist products serve various sectors including hospitals, biosafety labs, pharmaceutical facilities, commercial buildings, schools, and food processing facilities.

TOMI Environmental Solutions (NASDAQ: TOMZ), a global disinfection and decontamination solutions company, has appointed David Vanston as Chief Financial Officer effective May 30, 2025. Vanston brings over 25 years of international financial leadership experience across life sciences, manufacturing, and technology sectors. He previously held CFO positions at Jon-Don, Flexan, Arcmed-Diba Industries, and VolitionRx. Vanston holds an MBA from Warwick University and is a Fellow of the Chartered Certified Accountants in the UK. He succeeds Nick Jennings, who is retiring. TOMI specializes in Binary Ionization Technology (BIT) platform, developed under a DARPA defense grant, which uses ionized Hydrogen Peroxide technology for superior disinfection across various sectors including healthcare, biosafety, pharmaceutical, commercial, and food processing facilities.